Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (11516)	12/20/2018 1:40:06 PM
From: mattstat	Read Replies (1) \| Respond to of 12874

Well you got the stock to sell down to 29 cents so far. So the "rumor" is working.

To: HardToFind who wrote (11516)	12/20/2018 2:53:21 PM
From: old 'n cranky	1 Recommendation Recommended By mattstat Read Replies (1) \| Respond to of 12874

Sorry if it appeared that I was claiming it was true. It didn't and I didn't say that it did. I just suggested that it wasn't credible. To me the fact that a rumor is "seemingly tracking back to insiders"...or former insiders...only enhances its lack of credibility, due to both the "seemingly" and the lack of credibility of virtually all of the insiders. It strikes me that the FDA would be highly unlikely to preemptively address the provenance of a drug candidate for which an IND hasn't even been filed, especially going so far as to be "forcing Diwan & TheraCour to untangle their parasite-host relationship with NNVC". Does that really seem reasonable to you? I'm not asking if there is some slippery "grain of truth" justification for repeating it but whether it actually seems reasonable. I don't believe that it does. It's that simple. You thought that it had enough of a basis to report it publicly, adding disclaimer language while suggesting that it might be reasonable. I don't believe it to be reasonable.